Identification of candidate repurposable drugs to combat COVID-19 using a signature-based approach
Abstract The COVID-19 pandemic caused by the novel SARS-CoV-2 is more contagious than other coronaviruses and has higher rates of mortality than influenza. Identification of effective therapeutics is a crucial tool to treat those infected with SARS-CoV-2 and limit the spread of this novel disease gl...
Guardado en:
Autores principales: | Sinead M. O’Donovan, Ali Imami, Hunter Eby, Nicholas D. Henkel, Justin Fortune Creeden, Sophie Asah, Xiaolu Zhang, Xiaojun Wu, Rawan Alnafisah, R. Travis Taylor, James Reigle, Alexander Thorman, Behrouz Shamsaei, Jarek Meller, Robert E. McCullumsmith |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/183b0c4e766e453cac438874bd544e5b |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Strategies to identify candidate repurposable drugs: COVID-19 treatment as a case example
por: Ali S. Imami, et al.
Publicado: (2021) -
Using protein turnover to expand the applications of transcriptomics
por: Marissa A. Smail, et al.
Publicado: (2021) -
Cellular, molecular, and therapeutic characterization of pilocarpine-induced temporal lobe epilepsy
por: Nicholas D. Henkel, et al.
Publicado: (2021) -
Public-private partnerships for innovation and export development: the Irish model of development
por: O'Donovan, David
Publicado: (2014) -
Repurposing a chemosensory macromolecular machine
por: Davi R. Ortega, et al.
Publicado: (2020)